
Please try another search
Coegin Pharma AB, a biotechnology company, engages in developing peptide-based products for hair growth and skin pigmentation in Sweden. The company develops Follicopeptide, a peptide designed to enhance hair growth; and NPP-4, a natural pigmentation peptide 4 works by facilitating the transport of melanin to the skin, mimicking the natural process that occurs during sun exposure or tanning beds. It is also developing FOL026, a drug candidate which is in preclinical trial for the treatment of myocardial infarction; AVX420, a drug candidate which is in preclinical trial for the treatment of leukemia; and AVX001, a drug candidate which is in phase 2 clinical development to treat both actinic keratosis and basal cell carcinoma. Coegin Pharma AB was founded in 2005 and is based in Lund, Sweden.
Name | Age | Since | Title |
---|---|---|---|
Eva Sjokvist Saers | 61 | 2023 | Chairman of the Board |
Edward A. Dennis | 83 | - | Member of Scientific Advisory Board |
J. A. Jongejan | - | - | Member of Scientific Advisory Board |
Erlend Skagseth | 70 | 2020 | Director |
Thoas Fioretos | 63 | 2022 | Director |
Jens Eriksson | 50 | 2023 | CEO & Director |
Eva Sjokvist Saers | 63 | 2023 | Chairman of the Board |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review